TGA
Vaccination ad warning
Pharmacists reminded to get their vax service ads right Pharmacies are being reminded that they may only advertise a ‘vaccination service’ to the public and not the actual vaccines themselves. …
Mixed findings from codeine review
A review into the safety and efficacy of OTC codeine-containing medicines reports mixed findings The Australian review concluded that the drugs do provide significant pain relief but with little evidence of …
Vitamin recall
Vitamin batch recalled due to possible incorrect tablet inclusion A single batch of Betamin 100 mg vitamin B1 tablets is being recalled by the TGA, in collaboration with manufacturer Sanofi. …
Epipen warning issued
Regulator warns of safety issues after reports from pharmacies The TGA has issued a safety alert about an EpiPen Adrenaline Auto-injector produced by Alphapharm following reports from pharmacies in a …
In The News
Today in our news roundup: warnings over the timing of TGA staff cuts, and more revelations about big pharma’s business practices No time for cutbacks Revelations that the TGA plans …
Codeine decision by May
Rescheduling review announced by department as May decision date looms A decision on the controversial rescheduling of codeine is expected by May 2016, following a safety review, Department of Health …
ASMI warns consumers against buying CMs from overseas
ASMI says consumers should only purchase complementary medicines approved for supply in Australia because they are highly regulated by the TGA. “Australia’s system of regulating complementary medicines is one of …
Naloxone downschedule will save lives: Angelo Pricolo
The TGA has recommended that naloxone minijet be scheduled to Pharmacist Only medicine—a decision which will likely save lives, says Angelo Pricolo, the Brunswick pharmacist who made the submission. This …
ACMS interim decision: OTC codeine could go S4
The Pharmacy Guild of Australia has expressed concern at the proposed re-scheduling of codeine containing analgesics to Schedule 4, Prescription Only Medicine. The interim decision of the Advisory Committee on …
Ley slams pharma companies on delaying tactics
Health Minister Sussan Ley has criticised pharmaceutical companies for dragging their feet on bringing new drugs to the Australian market and prioritising applying to lucrative markets overseas. “Australia has a …
PWC outlines medicines industry challenges: Medicines Australia
The 2015 PricewaterhouseCoopers survey of the Australian medicines industry provides an important and timely insight into the challenges and opportunities confronting the Australian innovative medicines industry, says Medicines Australia. The …
Regulatory headaches stifling access to medicines: PwC report
TGA regulation, price pressure and compliance issues are reducing access to medicines, and reducing industry confidence, a PwC report claims. Challenges and Change—a report on the Australian pharmaceutical industry, released …